Results 91 to 100 of about 1,959 (184)
Aswin Anand Pai, Ajith Mohan, Esther Sathya Bama Benjamin, Raveen Stephen Stallon Illangeswaran, Infencia Xavier Raj, Nancy Beryl Janet, Arun Kumar Arunachalam, ML Kavitha, Uday Kulkarni, Anup J Devasia, NA Fouzia, Aby Abraham, Alok Srivastava, Biju ...
Pai AA +16 more
doaj
The Dutch Pharmacogenetics Working Group (DPWG) describes gene-drug interactions to facilitate pharmacogenetic implementation in clinical practice. The current guideline describes the gene-drug interactions for TPMT, NUDT15 and thiopurines (azathioprine,
Nijenhuis, Marga +15 more
core +1 more source
NUDT15 variant and thiopurine-induced leukopenia in Hong Kong [PDF]
Felix C K, Wong +5 more
openaire +2 more sources
Background: Genetic variants of TPMT and NUDT15 have been reported to predict the inter-patient variability in response and toxicity profiles of patients receiving thiopurine therapy.
Wee Chian Lim +14 more
core +1 more source
Background: Thiopurines, including azathioprine and 6-mercaptopurine, are widely used in the treatment of inflammatory and autoimmune diseases, as well as hematological malignancies; however, their use is limited by the risk of severe myelosuppression ...
Irina R. Gilyazova +8 more
doaj +1 more source
Objective: This review aims to present and assess the existing scientific evidence on various genetic mutations of thiopurine S-methyltransferase (TPMT) and nucleoside diphosphate–linked moiety X-type motif 15 (NUDT15) and their potential implications in
Jayalakshmi Venugopal +2 more
doaj +1 more source
Pharmacogene Variation Consortium Gene Introduction:
Jun J. Yang +10 more
openaire +2 more sources
NUDT15, MRP4 and the development of precision medicine in Chile
Alonso De la Rivera Morales +3 more
openaire +1 more source
NUDT15Genotyping in Thiopurine Drug Therapy
Jong Kwon Lee, Rihwa Choi, Soo-Youn Lee
openaire +1 more source

